Status:
COMPLETED
Biomarkers for Intestinal Permeability
Lead Sponsor:
University of Hohenheim
Conditions:
Focus: Simplified Method to Assess Intestinal Permeability
Eligibility:
All Genders
18-70 years
Brief Summary
This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate markers for effortful "gold standard" methods.
Detailed Description
This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate markers for effortful "gold standard" methods. In healthy volunteers potential biomarkers for intestinal perm...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Written informed consent
Exclusion
- Underweight (BMI \<18 kg / m2) and obesity from grade II (BMI ≥ 30 kg / m2)
- Acute or chronic gastrointestinal diseases
- Chronically consuming diseases (e.g. chronic tumor disease, florid infections, etc.)
- Smokers (12 hours before the test and during the test it is not allowed to smoke)
- Ingestion of intestinal therapeutics, antibiotics, immunosuppressants or similar within the last 3 months
- Simultaneous participation in another clinical study
- Pregnancy / breastfeeding
- Intolerance to the sugar solution
- Occurrence of relevant diseases
- Revocation of consent
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2021
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04667208
Start Date
September 1 2020
End Date
January 7 2021
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hohenheim
Stuttgart, Germany, 70599